Issued by Khiron Life Sciences Corp
Khiron Life Sciences Corp, a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the release of its inaugural Environmental, Social and Governance (ESG) report which captures the period between January 1, 2020, and December 31, 2020, reflecting the Company’s commitment with sustainability.
Khiron’s responsibility with Sustainability
Showcasing the Company’s commitment to improving the lives of patients, employees, local communities, shareholders, and other stakeholders, along with environmental practices, the inaugural sustainability report outlines actions and initiatives undertaken in 2020 to strengthen ESG practices throughout the Company’s operations, along with Khiron’s goals for the short term. The report adheres to Global Reporting Initiative (GRI) Standards and reflects the alignment of the Company’s goals with the United Nations Sustainable Development Goals. A full copy of the report is available here.
“At Khiron, sustainability is embedded in our DNA. With the common belief that strong ESG policies improve performance, loyalty, and innovation, while reducing corporate risks and capital costs, our inaugural ESG report demonstrates our dedication to strong environmental, social and governance principles as we deliver on our Mission of improving lives through cannabis. I am proud of how our team rose to the challenges of 2020, achieving incredible milestones in an unprecedented year,” comments Alvaro Torres, CEO and Director.
Alvaro Torres, continues, “Increasingly, institutional investors are using ESG principles to guide investment decisions, and as one of the first global cannabis companies to publish an ESG report, we have achieved another corporate milestone that distinguishes us as an industry leader and market disruptor. We have set ambitious ESG goals for the next two years and I am confident our team will deliver on these objectives.”
2020 ESG Highlights
About Khiron Life Sciences Corp.
Khiron (or the “Company”) is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly owned medical health centers and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico in 2021. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
T: +1 (647) 556-5750
Vice President, Communications
Sustainability & Legal Leader
More from Khiron Life Sciences Corp